Vertex Pharmaceuticals, Inc.

( )
VRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -4.90%58.570.0%$919.92m
AMGNAmgen, Inc. 1.22%258.241.3%$759.50m
GILDGilead Sciences, Inc. 0.38%76.351.0%$735.36m
REGNRegeneron Pharmaceuticals, Inc. 2.18%622.452.5%$672.88m
NVAXNovavax, Inc. 2.43%81.64102.0%$616.96m
BIIBBiogen, Inc. 0.13%265.121.6%$544.40m
VRTXVertex Pharmaceuticals, Inc. 1.68%291.101.9%$526.40m
ILMNIllumina, Inc. 1.24%373.103.5%$309.63m
ALXNAlexion Pharmaceuticals, Inc. -0.08%112.302.0%$225.16m
BMRNBioMarin Pharmaceutical, Inc. 0.75%126.784.3%$216.16m
SGENSeattle Genetics, Inc. 0.90%169.036.1%$202.76m
SRNESorrento Therapeutics, Inc. -1.15%6.851.8%$187.20m
SRPTSarepta Therapeutics, Inc. -1.77%162.7513.9%$164.07m
INCYIncyte Corp. 3.72%106.472.5%$163.74m
IMMUImmunomedics, Inc. 1.71%37.5413.3%$157.98m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.